AzTrials
AzTrials

Pain, AcuteNCT05625776

Effects of Acute Pain on Cognitive Performance in Young Adults

A study testing pain delivery with capsaicin and heat and distractor delivery with sensory TENS in people with Pain, Acute and Cognition, run by University of Delaware at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The effects of pain on cognitive performance have not been thoroughly investigated. Broadly, the purpose of this research is to investigate the effects of acute pain on performance of a variety of cognitive performance measures. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Pain, Acute, Cognition
What is being tested?
pain delivery with capsaicin and heat and distractor delivery with sensory TENS
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
23 participants
Where
1 siteUnited States
Study dates
22 Mar 2023to 16 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18-35 years old
  • Self-identifying as generally medically healthy
  • Able to read, write and speak English
  • Able to provide informed consent
  • Willing to undergo the experimental pain or non-painful electrical stimulation, if selected

Who cannot join

  • Resting HR < 50 or > 100 bpm
  • Resting BP < 90/60 or > 140/95 mmHg
  • Any history or current mental health condition, learning/developmental disability or cognitive impairment, including ADD/ADHD, severe anxiety, severe depression, autism spectrum disorder, insomnia, mild cognitive impairment, etc.
  • Score on the MoCA <23
  • Score on the GAD-7 ≥ 10
  • Score on the PHQ-2 ≥ 2 and score on the PHQ-9 ≥ 10
Show all 19Show fewer
  • Any current (within last 3 month) or chronic medical conditions, including any musculoskeletal, cardiovascular, endocrine, pulmonary, metabolic, psychiatric or neurological diagnosis
  • Any implanted electronic medical devices (i.e., cardiac pacemakers, cardiac defibrillators, spinal cord neurostimulators)
  • Any impaired sensation or weakness in either lower extremity or in the area targeted for the stimulus
  • History of serious concussion or head injury, defined as a loss of consciousness for > 5 minutes and/or requiring medical treatment, or > 2 concussions over the lifespan
  • Any history of acute or chronic problems with balance, any dizziness, or > 1 fall in the last 12 months
  • Taking 4 or more medications
  • Currently or regularly using any analgesic medications, over-the-counter remedies, or any other treatment for the purposes of pain relief (i.e., baby aspirin for heart health permitted, etc.)
  • Any current or chronic pain condition during the last year, located anywhere in the body
  • Allergy to capsaicin or hot peppers
  • Any skin lesion, breakage or irritation in the area targeted for the painful stimulus
  • Skin sensitivity to soaps/creams/perfumes or to heat
  • Poor circulation in the area targeted for the painful stimulus
  • Prior participation in a locomotor learning study in this lab within the last 2 years

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Delaware

    Newark, Delaware, 19713

Other trials in United States

About this study

The effects of pain on cognitive performance have not been thoroughly investigated. Broadly, the purpose of this research is to investigate the effects of acute pain on performance of a variety of cognitive performance measures. The investigators hypothesize that acute pain impairs cognitive performance, particularly cognitive measures of working memory, attention, and processing speed.

Being tested
pain delivery with capsaicin and heat, distractor delivery with sensory TENS
Keywords
acute pain, cognition, pain, cognitive ability, young adults
Medical subject headings
Acute Pain, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pain delivery with capsaicin and heatProcedure or surgery

    Experimental pain paradigm delivered (capsaicin cream combined with heat) that is short-term and painful but not harmful

  • distractor delivery with sensory TENSProcedure or surgery

    Distractor stimulus delivered (sensory TENS electrical stimulation) that is short-term and attention-demanding but not painful

Study groups in NCT05625776
Study groupRoleWhat they receive
Pain StimulusExperimentalCapsaicin combined with heat applied to intact skin
Receives: Procedure: pain delivery with capsaicin and heat
Distractor Somatosensory StimulusActive comparatorSensory transcutaneous electrical nerve stimulation (TENS) applied to intact skin
Receives: Procedure: distractor delivery with sensory TENS
No StimulusNo interventionNothing applied to skin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Digit Span Forward & Backward Test

    number of digits (numbers) that can be repeated back in the same (DS forward) or the reverse (DS backward( order from which they were presented

    Measured: the change between baseline and delivery (during application of intervention)

  2. Trail Making Test A & B

    time required to draw a line connecting a series of numbers (TM-A) or a series of alternating letters and numbers (TM-B)

    Measured: the change between baseline and delivery (during application of intervention)

Secondary outcomes (12)
  1. Conner's Continuous Performance Test (CPT) 3

    response time for letters vs. 'x' stimuli; number of correct inhibited responses

    Measured: the change between baseline and delivery (during application of intervention)

  2. Hopkins Verbal Learning Test- Revised

    verbal memory for 3 semantic categories of 4 nouns each; immediate and delayed recall

    Measured: the change between baseline and delivery (during application of intervention)

  3. Brief Visuospatial Memory Test- Revised

    visual memory for 6 shapes and their location on a page; immediate and delayed recall and recognition

    Measured: the change between baseline and delivery (during application of intervention)

  4. Stroop Test

    response time and number of errors when stating the name of words printed in a congruent, neutral or incongruent color compared to the meaning of the words

    Measured: the change between baseline and delivery (during application of intervention)

  5. Wisconsin Card Sorting Test

    number of trials taken to deduce the new rule when the rules of a card game are changed without warning and without knowing what any of the rules are

    Measured: the change between baseline and delivery (during application of intervention)

  6. Delis Kaplan Executive Functional System (D-KEFS) - Verbal Fluency Section

    number of words stated that match a certain category or start with a certain letter in a given time period

    Measured: the change between baseline and delivery (during application of intervention)

  7. NIH Toolbox Picture Sequence

    reproduce the correct sequence of pictures

    Measured: the change between baseline and delivery (during application of intervention)

  8. NIH Toolbox Flanker

    response time and errors when asked to focus on a single visual stimulus amongst distractors

    Measured: the change between baseline and delivery (during application of intervention)

  9. NIH Toolbox List Sorting

    recall and sequencing of different visually and orally presented stimuli

    Measured: the change between baseline and delivery (during application of intervention)

  10. NIH Toolbox Dimension Change Card Sort

    errors selecting the correct dimension upon which to select a card, a cue for which is provided

    Measured: the change between baseline and delivery (during application of intervention)

  11. NIH Toolbox Pattern Comparison

    errors and time required to determine whether several sets of two pictures are the same or not

    Measured: the change between baseline and during application of intervention

  12. Wechsler 4th ed - Spatial Addition

    errors and time required to add or subtract the location of circles on a screen based on a given set of rules

    Measured: the change between baseline and delivery (during application of intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Nov 2022
  2. Study start22 Mar 2023
  3. Primary completion16 Nov 2023
  4. Study completion16 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05625776
Sponsor's protocol ID
1786370-1.2
Other IDs
R01AG071585
Status last verified
Dec 2023
First submitted
13 Nov 2022
Last updated
11 Dec 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing pain delivery with capsaicin and heat and distractor delivery with sensory TENS in people with Pain, Acute and Cognition, run by University of Delaware at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Digit Span Forward & Backward Test (time frame: the change between baseline and delivery (during application of intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in